| 摘要 |
<p>Compounds having sPLA2-inhibitory activities, which are compounds represented by general formula (I), prodrugs thereof, pharmaceutically acceptable salts of both, or solvates of them: wherein R1 is C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, a carbocyclic group, a heterocyclic group, or the like; R2 is a group containing 1 to 4 hydrogen or nonhydrogen atoms; RA is -COCONH¿2? or the like; R?3 is -(L2¿)-(acidic group) (wherein L2 is a group connecting with an acidic group); and R4 is hydrogen or the like.</p> |
